Wird geladen...
Metformin causes cancer cell death through downregulation of p53-dependent differentiated embryo chondrocyte 1
BACKGROUND: Metformin is the most commonly used first-line medicine for type II diabetes mellitus. Acting via AMP-activated protein kinase, it has been used for more than 60 years and has an outstanding safety record. Metformin also offers protection against cancer, but its precise mechanisms remain...
Gespeichert in:
| Veröffentlicht in: | J Biomed Sci |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6238313/ https://ncbi.nlm.nih.gov/pubmed/30442142 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-018-0478-5 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|